Locations:
SearchAdvertisement
Clinicians should individualize dosing practices based on patient risk factors and preferences
But findings apply only to middle-aged or older men with confirmed hypogonadism
Human and animal studies show a rise in platelet reactivity, thrombosis and cardiac events
ACC committee underscores need to properly weigh benefits in risk-benefit calculations
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Two major trials promise key progress against the last unaddressed major risk factor
Effect on gut microbiome emerges as another benefit of statin therapy
Phenylacetylglutamine acts via adrenergic receptors and is linked with cardiac events
Cardiac manifestations of this autoimmune disorder can be hidden but deadly
Medications for patients with diabetes and cardiovascular disease
Findings are from a large cohort study in patients with type 2 diabetes and obesity
Advertisement
Advertisement